Happy to provide a free copy if you cannot access it.
Posts by
Check out my latest publication summarizing the most recent evidence around reduced dose DOACs in secondary VTE prevention
#Hemesky
doi.org/10.1111/imj....
🚨FDA approves rilzabrutinib – 1st BTK inhibitor for ITP
LUNA3: heavily pre-treated pts (median 4 prior lines, 28% splenectomy), durable PLT response 23% vs 0% PBO; 64% initial rise; median 15d. ↓ rescue Rx, ↓ bleeding, ↑ QoL. Well-tolerated
Australia needs this! 🇦🇺
@thanzblood.bsky.social #hemesky
Results of HIPRO single centre RCT out In pts w/ provoked VTE + enduring risk (obesity, chronic inflammation, CVD, lung dz), 12 mo low-dose apixaban cut recurrence 1.3% vs 10% (HR 0.13, NNT≈12). Major bleed rare; CRNM bleed ↑ (NNH≈32). Subgroup analysis underpowered.
www.nejm.org/doi/full/10....
t(8;14) IGH-MYC. Rarely 2;8 or 8;22
Poll question for haematologists
Is there still a role for Activated Protein C Resistance testing in the assessment for thrombophilia, when FVL PCR is readily available?
1️⃣ YES
2️⃣ NO
Reply with number below.
#hemesky
Splenic marginal zone lymphoma
www.sciencedirect.com/science/arti...
I came across this “practical guideline” for major heritable thrombophilia. I am not sure I agree with some of their recommendations - should generate an interesting debate though. Also have never tested for the F2 AT resistance mutations!
#hemesky
Plasmodium falciparurm
Combined HbC trait and G6PD deficiency!
Biology resists simplicity #ISTH2025 plenary session
Babesiosis - the insert shows a Maltese Cross
Giant pronormoblasts seen in parvovirus B19
Fascinating paper; which reinforces my own clinical experience that the majority of clinically encountered type I protein S deficiency behave like a low risk thrombophilia, presumably as they have the missense variant. We need more studies like this!
jamanetwork.com/journals/jam...
Delighted to present our survey results on the management of superficial thrombophlebitis in the short saphenous vein when in close proximity to the saphenopopliteal junction at ISTH congress June 21-25, 2025.
If you’re there, come and check out our poster.
@isth.org #Hemesky
Hematology Breakthrough | Displaycia | Global Journal of Medical and Health Sciences Research (GJMHSR)
📢 Hematology Breakthrough! 🧑⚕️🔬
📌 Follow us for more updates: @displaycia.bsky.social
🔗 Read more: displaycia.com/medic...
#Hematology #HealthScience #Breakthrough #MedicalScience #ManuscriptSubmission #ScientificResearch #Innovation #Displaycia
Bottom line - the LLN for Ferritin in both women and men should be at least 30 in the absence of inflammation and chronic kidney disease.
Interstitial infiltration with monomorphic medium mature lymphocytes. Starry sky appearance would favour Burkitt but is not specific.
FARES-II: Much anticipated randomized trial @jama.com comparing Plasma to PCC in cardiac surgery (n=420)
Those in PCC arm had ↑ hemostatic efficacy and ↓ RBC transfusion
Hopefully practice-changing for many!
jamanetwork.com/journals/jam...
#transfusion #hemesky
@nejm.org
Finally! More data to add to the EVE trial
APICAT showed non inferiority of apixaban 2.5BD in patients with CAVTE who have completed 6m anticoagulation to 5BD in terms of VTE recurrence (2.1% v 2.8%) and lower clinically relevant bleeding (12.1% v 15.6%)
#Hemesky #BSH
www.nejm.org/doi/full/10....
doi.org/10.1182/hem....
This is a fantastic read. Strongly recommended. #Hemesky
Spherocytes lacking central pallor. Differential diagnosis warm autoimmune haemolytic anaemia, haemolytic transfusion reactions and hereditary spherocytosis
New in The Journal of Haemophilia Practice: a paper reporting on the hopes and goals of a group of men with #haemophilia B, including how new treatments, such as #genetherapy, could help support and redefine their aspirations. Open access here: loom.ly/vJmE2Wg
#HemeSky #BloodSky #MedSky
RPTH Cares about Women's Health 🌸: NAID and IDA are extremely prevalent among women, largely due to iron losses from vaginal blood loss.
Explore the findings: www.rpthjournal.org/article/S247...
@isth.org
#IronDeficiency #WomensHealth
#ASHWomenWednesday ♀️🩸: Learn about why hematologists should care about heavy periods, and test your knowledge with a quick quiz.
Share your insights in the comments!
#ASHEducation #ASHWomenWednesday #WomenInHeme #Shematology #BloodSisters #HemeHeroines #BloodEducation #Microlearning #Hematology